Accredo 深入见解

Learn how gene and cell therapies pose economic implications for payers and patients. Find out how specialty pharmacies support the therapy… Learn more

Accredo deliver's Hawaii's first ever ZOLGENSMA treatment. Learn more about ZOLGENSMA and why this SMA treatment can be crucial to improving… Learn more

Accredo Specialty Pharmacy can support your therapy before, during and after launch to increase your therapy’s success in a crowded oncology… Learn more

This article is a summary of a recent large-scale research study led by the Accredo specialty pharmacy clinical team. The study focused on specialty… Learn more

Accredo provides rare therapy manufacturers with powerful, customizable data insights that enhance decision-making and inform market strategies. Find… Learn more

The Rare Disease TRC customizes care to meet patients where they are in their care journey. 了解更多

Understanding these networks in a specialty pharmacy is crucial to making informed decisions about the distribution of therapies. Learn more. 了解更多

With a small percentage of rare conditions having treatment options, accessibility is often a barrier preventing patients from getting on and staying… Learn more

Bill Martin is the Chief Commercial Officer at Accredo by Evernorth. Find out how Bill leads the commercial team with passion and purpose. 了解更多

Nutrition is vital for patients undergoing cancer therapies. Discover how the TherapEase Cuisine program can help ease the challenges of oncology… Learn more

Neurologist Dr. Diana Castro sits down with Accredo’s Diana Florio and shares her passion for holistic patient care and what lies ahead for… Learn more

Jim Blondin, RPh, MBA, serves as the senior director of the Product Solutions team, leading the charge in digital innovation at Accredo by Evernorth.… 了解更多